Russell T. Kronengold
Profile
Russell T.
Kronengold worked as Vice President-Biomaterials Research at DSM Biomedical, Inc. from 1997 to 2010.
He also worked as Chief Scientific Officer at Aperion Biologics, Inc. Additionally, he received an undergraduate degree from Carnegie Mellon University, a doctorate degree from the University of Medicine & Dentistry of New Jersey, and a graduate degree from Rutgers State University of New Jersey.
Former positions of Russell T. Kronengold
| Companies | Position | End |
|---|---|---|
DSM Biomedical, Inc.
 DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Corporate Officer/Principal | 15/02/2010 |
| APERION BIOLOGICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Russell T. Kronengold
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| Carnegie Mellon University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
DSM Biomedical, Inc.
DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Health Technology |
Aperion Biologics, Inc.
 Aperion Biologics, Inc. Medical DistributorsDistribution Services Aperion Biologics, Inc. engages in the development and implementation of its business plans, performing research on its platform technology, conducting clinical trials on its products in both animals and humans, pursuing regulatory approvals to market its product in U.S. and international markets, and raising capital. The firm's core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both humanizes and sterilizes the tissues without affecting their biomechanical or biological properties. The company was founded by Kevin Robert Stone in October 1996 and is headquartered in San Antonio, TX. | Distribution Services |
- Stock Market
- Insiders
- Russell T. Kronengold
